• SPX
  • 5987.37
  • 0.3 %
  • 18.0303
  • DJI
  • 44736.57
  • 0.99 %
  • 440.0586
  • N225
  • 38442
  • -0.87 %
  • -338.1406
  • FTSE
  • 8249.59
  • -0.51 %
  • -42.09
  • IXIC
  • 19054.836
  • 0.27 %
  • 51.1855
Corvus Pharmaceuticals, Inc. (CRVS) Latest News

Corvus Pharmaceuticals, Inc. (CRVS) Latest News

NASDAQ Currency in USD Disclaimer

Stock Price

$8.94

-$0.02

(-0.17%)

Day's range
$8.87
Day's range
$9.35

Latest News of CRVS

Corvus Pharmaceuticals Inc (CRVS) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid ...

By Yahoo! Finance | 1 week ago

CEO Richard Miller discusses the quick response kinetics of ITK inhibition on atopic dermatitis in the earnings call. Initial improvements are expected within a week, with a durable effect similar to ...

Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) stock price dropped 12% last week; retail investors would not be happy

By Yahoo! Finance | 5 months ago

Retail investors hold the majority of shares in Corvus Pharmaceuticals, Inc. Institutions and hedge funds also have significant ownership. Insider ownership is positive, and the general public holds a...

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.